Medicaid

Trump’s Blueprint on International Drug Pricing; What to Expect

The U.S. always stood out as a different healthcare system. Well, maybe not anymore. The Trump Administration released an International Drug Pricing blueprint in 2018 and it was received with…

Read Full Article

Discount Safe Harbor Proposed Rule: How Process Works and What does it mean?

July 2019 Update As first reported by The Wall Street Journal and Axios on July 11, 2019, the Trump Administration has decided to abandon implementation of the proposed Discount Safe…

Read Full Article

Challenges with Health Plan Re-accreditation

As NCQA Health Plan re-accreditation quickly approaches for many health plans this year, in addition to ensuring certain areas are accreditation ready, the quality and clinical teams at your health…

Read Full Article

CMS message at HIMSS: Overhauling “meaningful use”, ensuring interoperability, and patient-ownership of data

Co-authored by Chris McShanag, VP Healthcare Provider Solutions Last week in Las Vegas, Nevada, senior representatives from the Trump Administration and the Centers for Medicare and Medicaid Services (CMS) spoke at…

Read Full Article

4 Changes to the AMP Final Rule with Immediate Impacts on Regulatory Systems

On January 21, 2016, CMS released an advance-print copy of the long-awaited final rule on the Medicaid Drug Rebate Program (MDRP). The final rule implements various statutory amendments, revises the…

Read Full Article